Press Releases Federal Officials Should Investigate Conduct of Alzheimer’s Disease Trials October 23, 2024
Press Releases Medical Advocate Urges FDA Against Perceived “Done Deal” Approval of Lecanemab January 5, 2023
Press Releases Congressional Committee Releases Report, Internal FDA Documents on Aduhelm December 29, 2022
Press Releases FDA Must Promptly Withdraw Approval of Medication for Prevention of Preterm Birth October 18, 2022
In the News STAT Opinion: NEJM, other journals: provide more transparency about conflicts of interest or don’t publish conflicted articles May 19, 2022
Press Releases Statement: FDA’s Reckless Decision to Approve Ineffective Alzheimer’s Disease Drug Causing Financial Pain for All Medicare Part B Beneficiaries November 15, 2021
Press Releases Statement: Inspector General’s Decision To Investigate FDA’s Inappropriately Close Collaboration With Biogen on the Alzheimer’s Disease Drug Aducanumab Is Long Overdue August 4, 2021